MED16
Mediator of RNA polymerase II transcription subunit 16 · Q9Y2X0 · MED16 on Sugi Atlas →
0 patent compounds predicted against MED16, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to MED16 by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a MED16 binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| Q6PGF3 | — | 1.000 | Q6PGF3 → |
| Q566H4 | — | 1.000 | Q566H4 → |
| Q8WYP5 | — | 0.994 | Q8WYP5 → |
| Q9H2M9 | — | 0.993 | Q9H2M9 → |
| B1WC10 | — | 0.993 | B1WC10 → |
| Q08D69 | — | 0.992 | Q08D69 → |
| O95876 | — | 0.992 | O95876 → |
| O88480 | — | 0.991 | O88480 → |
| A2A9C3 | — | 0.991 | A2A9C3 → |
| Q8CEC0 | — | 0.990 | Q8CEC0 → |
| Q8C0M0 | — | 0.990 | Q8C0M0 → |
| Q9C0B7 | — | 0.990 | Q9C0B7 → |
| A7UA95 | — | 0.989 | A7UA95 → |
| Q80U93 | — | 0.989 | Q80U93 → |
| Q9QY53 | — | 0.989 | Q9QY53 → |
| Q8C3S2 | — | 0.989 | Q8C3S2 → |
| O75800 | — | 0.989 | O75800 → |
| Q15061 | — | 0.989 | Q15061 → |
| Q8BMG7 | — | 0.989 | Q8BMG7 → |
| Q99K74 | — | 0.988 | Q99K74 → |
| A2CEI4 | — | 0.988 | A2CEI4 → |
| Q5U1Z0 | — | 0.988 | Q5U1Z0 → |
| Q99ML0 | — | 0.988 | Q99ML0 → |
| F1QEB7 | — | 0.987 | F1QEB7 → |
| Q62141 | — | 0.987 | Q62141 → |
| Q8K1X1 | — | 0.987 | Q8K1X1 → |
| Q5ZLG9 | — | 0.987 | Q5ZLG9 → |
| Q16K67 | — | 0.987 | Q16K67 → |
| PIK3C2B | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0.987 | landscape → |
| Q6PFH3 | — | 0.987 | Q6PFH3 → |